XML 14 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash flows from operating activities:          
Net loss $ (483,729) $ 21,614 $ (1,853,915) $ (1,063,628)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     21,614 22,414  
Realized loss on marketable securities     60,143  
Unrealized loss on marketable securities   3,895 5,545  
Bad debts     151,772  
ROU asset amortization     109,660 109,963  
Change in assets and liabilities:          
Royalty receivables     145,335 (754,679)  
Prepaid expenses and other current assets     (73,640) (102,183)  
Accounts payable and accrued expenses     (44,889) 24,959  
Deferred revenue     3,586 13,304  
Operating lease liability     (135,232) (123,539)  
Net cash used in operating activities     (1,615,566) (1,867,844)  
Cash flows from investing activities:          
Purchases of fixed assets     (1,216) (966)  
Purchases of marketable securities     (3,433,633)  
Proceeds from sales of marketable securities     2,694,968 650,000  
Net cash provided by (used in) investing activities     2,693,752 (2,784,599)  
Cash flows from financing activities:          
Proceeds from sale of common stock and warrants     3,450,000  
Proceeds from exercise of options     86,262  
Net cash provided by financing activities     3,450,000 86,262  
Net increase (decrease) in cash and cash equivalents     4,528,186 (4,566,181)  
Cash and cash equivalents at beginning of period     269,964 4,772,705 $ 4,772,705
Cash and cash equivalents at end of period $ 4,798,150 $ 206,524 $ 4,798,150 $ 206,524 $ 269,964